U.S. markets open in 3 hours 50 minutes

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.65+0.08 (+0.39%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close20.57
Open20.64
Bid0.00 x 800
Ask0.00 x 800
Day's Range20.57 - 21.25
52 Week Range12.98 - 30.65
Volume436,427
Avg. Volume670,385
Market Cap894.764M
Beta (5Y Monthly)0.48
PE Ratio (TTM)10.32
EPS (TTM)2.00
Earnings DateAug 05, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 01, 2019
1y Target Est29.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
14% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
    GlobeNewswire

    Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference

    CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will participate in a live, virtual fireside chat at the 41st Annual William Blair Growth Stock Conference on Wednesday, June 2, 2021 at 4:20 PM ET. Jack Kenny will also pre-record a presentation for the Jefferies Virtual Healthcare Conference which will be webcast on Friday, June 4, 2021 at 2:00 PM ET. Jack Kenny will be taking 1x1 meetings at the William Blair conference while Bryan Baldasare, Executive Vice President and Chief Financial Officer, and Charlie Wood, Vice President – Investor Relations, are taking 1x1 meetings at the Jefferies conference. To access these presentations, go the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/. Participants should register several minutes in advance of the William Blair event’s start time by following the link provided for the event. A recording of this event will be available for 30 days. The pre-recorded presentation for the Jefferies event will be made available for 90 days starting June 4. About Meridian Bioscience, Inc.Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world. Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Contact:Charlie WoodVice President – Investor RelationsMeridian Bioscience, Inc.Phone: +1 513.271.3700Email: mbi@meridianbioscience.com

  • Is Weakness In Meridian Bioscience, Inc. (NASDAQ:VIVO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
    Simply Wall St.

    Is Weakness In Meridian Bioscience, Inc. (NASDAQ:VIVO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

    It is hard to get excited after looking at Meridian Bioscience's (NASDAQ:VIVO) recent performance, when its stock has...

  • Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples
    GlobeNewswire

    Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples

    CINCINNATI, May 17, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Plant Mix. This unique Mix is specifically designed to develop and manufacture multiplexed highly sensitive and economical molecular field-tests in agriculture biotechnology (AgBio). Increasing global food demand due to the growth in the human population accelerated the need for better crop health monitoring and surveillance. The requirements for constant monitoring of transgenic DNA from genetically modified organisms (GMO), coupled with the need for more reactive crop disease management with fast pathogen detection, led to the adoption of molecular techniques such as qPCR in agricultural diagnostics. While extraction of DNA from the plant sample before qPCR analysis does allow for the removal of various plant metabolites inhibiting the analysis, it is also a laborious and expensive activity. Meridian has developed an innovative solution for direct qPCR workflows using crude plant lysates without nucleic acid purification. Meridian’s Air-Dryable™ Direct DNA qPCR Plant Mix uses a unique polymerase and buffer system, optimized explicitly for direct amplification from crude plant lysates – removing the need for purification of DNA from the sample. In addition, with its uniquely high 4x concentration format, the Air-Dryable™ Direct DNA qPCR Plant Mix facilitates the development of ambient temperature stable assays without the need for lyophilization – making it ideal for manufacturing field-friendly, highly sensitive, and cost-effective molecular plant assays. Lourdes Weltzien, PhD, Executive Vice President – Life Science commented, “Air-dryable master mixes create a paradigm shift for molecular assay manufacturers. Room-temperature stable assays can now be created with an optimized master mix that can be oven-dried on site. Manufacturers can save time, reduce cost, and control their entire manufacturing workflow, while delivering the same or better performance as compared to other assay-formats. With the ability to use our Air-Dryable™ Direct DNA qPCR Plant Mix with crude samples, the testing process is faster and more economical than ever before.” Meridian is committed to providing innovative solutions to diagnostic manufacturers that simplify and accelerate the development of superior assays. For more information about partnering with Meridian Bioscience, please visit https://meridianlifescience.com/air-dryable-mixes or contact Morey Setareh, Senior Director, Sales & Marketing at morey.setareh@meridianlifescience.com. About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world. Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Contact: Charlie WoodVice President – Investor RelationsMeridian Bioscience, Inc.Phone: +1 513.271.3700Email: mbi@meridianbioscience.com